Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Aug 13;18(1):396.
doi: 10.1186/s12879-018-3316-1.

Hospitalization rates and outcome of invasive bacterial vaccine-preventable diseases in Tuscany: a historical cohort study of the 2000-2016 period

Affiliations

Hospitalization rates and outcome of invasive bacterial vaccine-preventable diseases in Tuscany: a historical cohort study of the 2000-2016 period

Elena Chiappini et al. BMC Infect Dis. .

Abstract

Background: Invasive bacterial diseases (IBD) are a serious cause of hospitalization, sequelae and mortality. Albeit a low incidence, an increase in cases due to H. influenzae was registered in the past 4 years and, in the Tuscany region, an excess of cases due to N. meningitidis since 2015 is alarming. The purpose of this study is to deepen the knowledge of IBD epidemiology in Tuscany with particular attention to temporal trends.

Methods: Tuscan residents hospitalized for IBD from January 1st 2000 to March 18th 2016 were selected from the regional hospital discharge database based on ICD-9-CM codes. Age-specific and standardized hospitalization rates were calculated together with case-fatality rates (CFRs). A time-trend analysis was performed; whereas, prognostic factors of death were investigated through univariable and multivariable analyses.

Results: The average standardized hospitalization rates for invasive meningococcal diseases (IMD), invasive pneumococcal diseases and invasive diseases due to H. influenzae from 2000 to 2016 were 0.6, 1.8, and 0.2 per 100,000, respectively. The average CFRs were 10.5%, 14.5% and 11.5% respectively with higher values in the elderly. Older age was significantly associated with higher risk of death from all IBD. A significant reduction in hospitalization rates for IMD was observed after meningococcal C conjugate vaccine introduction. The Annual Percentage Change (APC) was -13.5 (95% confidence interval (CI) -22.3; -3.5) in 2005-2013 but has risen since that period. Furthermore, a significant increasing trend of invasive diseases due to H. influenzae was observed from 2005 onwards in children 1-4 years old (APC 13.3; 95% CI 0; 28.3).

Conclusions: This study confirms changes in the epidemiology of invasive diseases due to H. influenzae and IMD. Furthermore, attention is called to the prevention of IBD in the elderly because of the age group's significantly higher rate of hospitalizations and deaths for all types of IBD.

Keywords: Hospitalization, trend; Invasive bacterial diseases.

PubMed Disclaimer

Conflict of interest statement

The project has been approved by the Ethics Committee of the university hospital “Azienda Ospedaliero-Universitaria Meyer” of Florence on October 4th 2010 (authorization number 2010/7880). Data were obtained from an electronic database using ICD-9-CM. A specific informed consent was not considered necessary according to the Ethics Committee approving the project, because this was a descriptive epidemiological study performed on administrative data, which are routinely collected from any hospitalized patient after obtaining his/her consent. Furthermore, no human experimentation was foreseen by the study and patient information was anonymized and de-identified prior to analysis.

Not applicable.

The authors declare that they have no competing interests. CdW is Associate Editor of BMC Health Services Research and BMC Infectious Diseases.

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Figures

Fig. 1
Fig. 1
Case-fatality rates (CFRs) per type of IBD from 2000 to 2016
Fig. 2
Fig. 2
Age-specific HRs of invasive H. influenzae diseases in children below 4 years of age and Hib vaccination coverage in Tuscan children from 2003 to 2015

References

    1. European Centre for Diseases Prevention and Control (ECDC). Surveillance of invasive bacterial diseases in Europe. Stockholm. 2011:2013. 10.2900/1510.
    1. World Health Organization (WHO). Meningococcal meningitis. Fact Sheet N°141 2015. http://www.who.int/mediacentre/factsheets/fs141/en/. (Accessed 3 June 2016).
    1. Rosenstein NE, Perkins BA, Stephens DS, Popovic T, Hughes JM. Meningococcal disease. N Engl J Med. 2001;344:1378–1388. doi: 10.1056/NEJM200105033441807. - DOI - PubMed
    1. Stein-Zamir C, Shoob H, Sokolov I, Kunbar A, Abramson N, Zimmerman D. The clinical features and long-term sequelae of invasive meningococcal disease in children. Pediatr Infect Dis J. 2014;33:777–779. doi: 10.1097/INF.0000000000000282. - DOI - PubMed
    1. van de Beek D. Progress and challenges in bacterial meningitis. Lancet. 2012;380:1623–1624. doi: 10.1016/S0140-6736(12)61808-X. - DOI - PubMed

Publication types

MeSH terms

Substances